Literature DB >> 2685703

Papillo-renal syndrome. An inherited association of optic disc dysplasia and renal disease. Report and review of the literature.

A J Bron1, S E Burgess, P N Awdry, D Oliver, G Arden.   

Abstract

A family is described in which the father and son had chronic renal disease of early onset and bilateral optic nerve dysplasia. A further son, known to have microphthalmos died of renal disease in childhood. Optic nerve changes included coloboma in the father and Handmann's optic nerve anomaly, a condition resembling the morning glory syndrome (M.G.S.), in the son. There was electrodiagnostic and visual field evidence of optic nerve dysfunction even where acuity was relatively unaffected. The son developed central serous retinopathy, a condition frequently encountered in association with optic nerve dysplasias, including M.G.S.

Entities:  

Mesh:

Year:  1989        PMID: 2685703     DOI: 10.3109/13816818909009875

Source DB:  PubMed          Journal:  Ophthalmic Paediatr Genet        ISSN: 0167-6784


  4 in total

1.  Diagnosing papillorenal syndrome: see the optic papilla.

Authors:  Cameron F Parsa; Afshin Parsa
Journal:  Pediatr Nephrol       Date:  2008-05-30       Impact factor: 3.714

2.  Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations.

Authors:  L A Schimmenti; H E Cunliffe; L A McNoe; T A Ward; M C French; H H Shim; Y H Zhang; W Proesmans; A Leys; K A Byerly; S R Braddock; M Masuno; K Imaizumi; K Devriendt; M R Eccles
Journal:  Am J Hum Genet       Date:  1997-04       Impact factor: 11.025

3.  Demonstration of exclusive cilioretinal vascular system supplying the retina in man: vacant discs.

Authors:  C F Parsa; E W Cheeseman; I H Maumenee
Journal:  Trans Am Ophthalmol Soc       Date:  1998

4.  The prevalence of PAX2 mutations in patients with isolated colobomas or colobomas associated with urogenital anomalies.

Authors:  H E Cunliffe; L A McNoe; T A Ward; K Devriendt; H G Brunner; M R Eccles
Journal:  J Med Genet       Date:  1998-10       Impact factor: 6.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.